About MIR BIOSCIENCES INC.
MirBio develops T cell detection assays and immunogen design services that leverage non-infectious bacterial proteins to activate T cells for disease detection and treatment. The company is based in New Jersey, USA.
T cell detection assays using whole blood testsCustom T cell immunogen design servicesDevelopment of protein-based vaccines that train T cells to respond to external threatsProduction of disease-specific antigens for research use
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to MIR BIOSCIENCES INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.